While targeted inhibitors show tremendous promise, the abstract identifies ongoing challenges about optimal usage strategies. This gap affects treatment protocols and patient outcomes in a chronic pediatric condition. Gap type: open_question Source paper: Pediatric low-grade glioma: State-of-the-art and ongoing challenges. (None, None, PMID:37944912)
Landscape Summary: How can targeted inhibitor use be optimized for maximum efficacy in pediatric low-grade glioma? is a 0.82 priority gap in neuro-oncology. It has 0 linked hypotheses with average composite score 0.000. Status: open.
Colonna, Sevlever, et al. (TREM2 biology)
How can targeted inhibitor use be optimized for maximum efficacy in pediatric low-grade glioma? — INVOKE-2 (completed)
No hypotheses linked to this gap yet.
No knowledge graph edges recorded
No activity recorded yet.
No discussions yet. Be the first to comment.
Create sub-tasks to investigate specific aspects of this gap: